Beta cell function in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2 year double-blind randomised controlled study

被引：0
|
作者：
Johansen, O. [1 ]
Boehm, B. [2 ]
Grill, V. [3 ]
Torjesen, P. A. [4 ]
Bhattacharya, S. [5 ]
Patel, S. [6 ]
Wetzel, K. [5 ]
Woerle, H. -J. [7 ]
机构：
[1] Boehringer Ingelheim GmbH & Co KG, Asker, Norway
[2] Univ Ulm, D-89069 Ulm, Germany
[3] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway
[4] Aker Univ Hosp, Oslo, Norway
[5] Boehringer Ingelheim GmbH & Co KG, Biberach, Germany
[6] Boehringer Ingelheim GmbH & Co KG, Bracknell, Berks, England
[7] Boehringer Ingelheim KG, Ingelheim, Germany
来源：
DIABETOLOGIA | 2012年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
148
引用
收藏
页码：S67 / S68
页数：2
相关论文
共 50 条
  • [41] Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment A 1-year, randomized, double-blind, placebo-controlled study
    McGill, Janet B.
    Sloan, Lance
    Newman, Jennifer
    Patel, Sanjay
    Sauce, Christophe
    von Eynatten, Maximilian
    Woerle, Hans-Juergen
    DIABETES CARE, 2013, 36 (02) : 237 - 244
  • [42] High dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled study
    Sihag, B.
    Meena, B.
    Agrawal, R.
    Meel, J.
    Sirohi, P.
    Bishnoi, P.
    DIABETES OBESITY & METABOLISM, 2010, 12 : 87 - 88
  • [43] Effect of Human Proislet Peptide 2B on β-Cell Function in Subjects with Metformin-Treated Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Study
    Watkins, Elaine
    Morrow, Linda
    Krentz, Andrew
    Feig, Peter
    Upham, Lori
    Reiser, Joe
    Hompesch, Marcus
    DIABETES, 2016, 65 : A272 - A273
  • [44] Review of the Safety and Efficacy of Linagliptin as Add-On Therapy to Metformin in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Study
    Rendell, Marc
    Chrysant, Steven G.
    POSTGRADUATE MEDICINE, 2011, 123 (04) : 183 - 186
  • [45] Decline Pattern of Beta-cell Function in Adult-onset Latent Autoimmune Diabetes: an 8-year Prospective Study
    Li, Xia
    Chen, Yan
    Xie, Yuting
    Xiang, Yufei
    Yan, Xiang
    Huang, Gan
    Zhou, Zhiguang
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (07): : 2331 - 2340
  • [46] Effects of add on PTH(1-84) substitution therapy in hypoparathyroidism: Results from a double-blind randomised controlled study
    Sikjaer, T. T.
    Rejnmark, L.
    Mosekilde, L.
    BONE, 2011, 48 : S83 - S83
  • [47] Effects of dulaglutide and trelagliptin on beta cell function in patients with type 2 diabetes: a randomised controlled study: DUET-beta study
    Kondo, Y.
    Satoh, S.
    Terauchi, Y.
    DIABETOLOGIA, 2018, 61 : S388 - S388
  • [48] Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial
    Ridderstrale, Martin
    Andersen, Knut Robert
    Zeller, Cordula
    Kim, Gabriel
    Woerle, Hans J.
    Broedl, Uli C.
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (09): : 691 - 700
  • [49] Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
    von Herrath, Matthias
    Bain, Stephen C.
    Bode, Bruce
    Clausen, Jesper Ole
    Coppieters, Ken
    Gaysina, Leylya
    Gumprecht, Janusz
    Hansen, Troels Krarup
    Mathieu, Chantal
    Morales, Cristobal
    Mosenzon, Ofri
    Segel, Stine
    Tsoukas, George
    Pieber, Thomas R.
    LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (04): : 212 - 224
  • [50] Dapagliflozin vs glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin: 52-week results of a double-blind, randomised, controlled trial
    Nauck, M.
    Del Prato, S.
    Rohwedder, K.
    Elze, M.
    Parikh, S.
    DIABETOLOGIA, 2010, 53 : S107 - S107
12345